SE415252B - Sett att framstella nya oxifenylbutazonderivat - Google Patents

Sett att framstella nya oxifenylbutazonderivat

Info

Publication number
SE415252B
SE415252B SE7508543A SE7508543A SE415252B SE 415252 B SE415252 B SE 415252B SE 7508543 A SE7508543 A SE 7508543A SE 7508543 A SE7508543 A SE 7508543A SE 415252 B SE415252 B SE 415252B
Authority
SE
Sweden
Prior art keywords
oxifenyl
butazon
derivatives
make new
new
Prior art date
Application number
SE7508543A
Other languages
English (en)
Other versions
SE7508543L (sv
Inventor
D Rahtz
H Koch
E Gerhards
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7508543L publication Critical patent/SE7508543L/sv
Publication of SE415252B publication Critical patent/SE415252B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32—Oxygen atoms
    • C07D231/34—Oxygen atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7508543A 1974-07-29 1975-07-28 Sett att framstella nya oxifenylbutazonderivat SE415252B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2436882A DE2436882A1 (de) 1974-07-29 1974-07-29 Neue oxyphenylbutazon-derivate und ihre herstellung

Publications (2)

Publication Number Publication Date
SE7508543L SE7508543L (sv) 1976-01-30
SE415252B true SE415252B (sv) 1980-09-22

Family

ID=5922046

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7508543A SE415252B (sv) 1974-07-29 1975-07-28 Sett att framstella nya oxifenylbutazonderivat

Country Status (20)

Country Link
US (1) US3968219A (sv)
JP (1) JPS5136452A (sv)
AT (1) AT344689B (sv)
AU (1) AU8332175A (sv)
BE (1) BE831855A (sv)
CA (1) CA1062264A (sv)
CH (2) CH617926A5 (sv)
CS (1) CS197252B2 (sv)
DD (1) DD122533A5 (sv)
DE (1) DE2436882A1 (sv)
DK (1) DK137009C (sv)
ES (1) ES439810A1 (sv)
FR (1) FR2280374A1 (sv)
GB (1) GB1519498A (sv)
HU (1) HU170518B (sv)
IE (1) IE41639B1 (sv)
IL (1) IL47768A (sv)
NL (1) NL7509060A (sv)
SE (1) SE415252B (sv)
SU (1) SU593662A3 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915184D0 (en) * 1999-06-29 1999-09-01 Viral As A Compounds
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
CA2566228A1 (en) * 2004-05-12 2005-11-17 A-Viral Asa Method of tonic treatment with oxyphenbutazone derivatives
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
KR20150055082A (ko) 2010-03-26 2015-05-20 갈데르마 리써어치 앤드 디벨로프먼트 홍반의 유효하고 안전한 치료를 위한 개선된 방법 및 조성물
AU2012324543B2 (en) 2011-10-19 2017-08-10 Galderma S.A. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5404M (sv) * 1965-09-08 1967-09-25
FR2054447B1 (sv) * 1969-07-03 1973-06-08 Synthelabo

Also Published As

Publication number Publication date
SU593662A3 (ru) 1978-02-15
SE7508543L (sv) 1976-01-30
IE41639L (en) 1976-01-29
BE831855A (fr) 1976-01-29
US3968219A (en) 1976-07-06
AU8332175A (en) 1977-01-27
HU170518B (sv) 1977-06-28
DK137009C (da) 1978-05-22
DK137009B (da) 1978-01-02
IL47768A (en) 1979-10-31
CS197252B2 (en) 1980-04-30
CH617927A5 (sv) 1980-06-30
DK344375A (da) 1976-01-30
IL47768A0 (en) 1975-10-15
CA1062264A (en) 1979-09-11
DD122533A5 (sv) 1976-10-12
DE2436882A1 (de) 1976-02-19
AT344689B (de) 1978-08-10
FR2280374B1 (sv) 1980-04-30
NL7509060A (nl) 1976-02-02
CH617926A5 (sv) 1980-06-30
JPS5136452A (sv) 1976-03-27
ES439810A1 (es) 1977-04-16
ATA583675A (de) 1977-12-15
GB1519498A (en) 1978-07-26
IE41639B1 (en) 1980-02-13
FR2280374A1 (fr) 1976-02-27

Similar Documents

Publication Publication Date Title
SE420718B (sv) Sett att framstella nya dekapeptidamidderivat med ovalationsinducerande aktivitet
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE425244B (sv) Sett att framstella 4-hydroxi-3-kinolin-karboxamidderivat
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE408300B (sv) Sett att framstella nya dipeptidderivat
SE7602729L (sv) Sett att framstella nya indolylalkylpiperidiner
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE7511328L (sv) Sett att framstella nya pyridinderivat
SE425312B (sv) Sett att framstella morfolinderivat
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE425850B (sv) Sett att framstella abietamidderivat.
SE427655B (sv) Sett att framstella abietamidderivat
SE7509209L (sv) Sett att framstella nya kinolinderivat
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat
SE428471B (sv) Sett att framstella imidazolderivat
SE412233B (sv) Sett att framstella nya fenotiazinderivat
SE7609666L (sv) Sett att framstella nya 5-aminometyltiazolderivat
SE7508779L (sv) Sett att framstella prostaninsyraderivat
SE7506571L (sv) Sett att framstella nya bufatrienolidramnosideter
SE408170B (sv) Sett att framstella nya substituerade nitrobensofenonderivat
SE420722B (sv) Sett att framstella benshydryloxi-alkylaminderivat
SE439303B (sv) Sett att framstella nya aminoetanolderivat